Covi-Pantel . NZ Trader Release

One Step Closer to a Global Bio Oral Available Treatment for SARS & SARS 2 Virus

Pharmaust again today have confirmed the previously announced data that Monepantel eliminates 95% of Cov 19 Virus Cells in 72 hours.

The Trials have been confirmed in conjunction with the asture and well respected WEHI Walter & Eliza Hall Institute with a High Degree of Oversight due to significant Govt funding.

Pharmaust being the consummate proffesionals that they are will now move on swiftly to carry out necessary trials to enable the Treatment to be administered to Human Patients that have regretably contacted the Cov19 Virus.

Pharmaust has confirmed they have filed Patents for the Protection of the Scientific Discoveries for the benefit of Pharmaust Share Holders.

The Company may now call upon all of its resources to accelerate the timely commercialisation of a Safe in home treatment for Cov 19 and Variant mutations that fall with in the SARs and SARs-2 Virus Family.


Hoping the company will also replicate the previously successful Human Oncology Phase II Trials V2.0


K9 Cancer Treatment
Pharmaust last month delivered the K9 Lymphoma Phase I and II Trials Data Dossier to VM, Pharmaust are in the enviable position to have a Manufacturing and Distribution agreement penned with a Fortune 500 ,Global Vetrinary Distributor.



During this busy time the company have also been monitoring previous GMP batches of Tablets , for stability and preservation of efficacy.

Best of Luck to fellow SH,,